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Purpose	Ovarian cancer is the most fatal of all gynecologic cancers, with a high relapse rate regardless of
stage. Women treated for ovarian cancer, therefore, likely have supportive care needs that extend well
beyond the time frame of first-line therapy. Unfortunately, there is minimal data describing these needs.
The purpose of this qualitative study is to understand the supportive care needs of women with ovarian
care at the end of treatment.
Methods	To better understand the issues faced by women with ovarian cancer, we conducted a public Twitter
chat in collaboration with gynecologic cancer social media (#gyncsm). Both quantitative and qualitative
analyses were performed.
Results 	The chat occurred over a 1-hour time frame on Twitter and resulted in more than 300 unique and original
tweets from 43 participants during the chat and an additional 60 unique participants following the chat.
Survivors and physicians represented 32% and 11% of participants, respectively; caregivers, advocates,
and other clinicians represented the remaining participants. Participants noted deep interest in receiving
support during survivorship and dissatisfaction with currently available resources. Sentiment analysis
showed that participants viewed the support from social media in a positive light and also revealed
negative sentiment around the lack of support from health care providers at the end of treatment.
Conclusions	Themes derived from the Twitter chat revealed the unique experiences of individuals with ovarian
cancer after treatment, including a heightened sense of vulnerability. Understanding these themes
represents an opportunity for clinicians to better understand and address the needs of this patient
community. (J Patient Cent Res Rev. 2018;5:149-157.)
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modalities have increased survival rates for patients
with more limited disease, the supportive needs
of patients continue well beyond active cancer
treatment.4-6
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In 2006, the Institute of Medicine recommended that
every patient completing primary treatment receive a
“comprehensive care summary and follow-up plan.”7
Despite recommendations for survivorship care plans
to summarize participants’ treatments, ongoing therapy,
follow-up visits, cancer screening and surveillance,
late- and long-term effects, and psychosocial concerns,

ndividuals who complete treatment for ovarian
cancer are known to experience a high number
of unaddressed needs.1,2 Ovarian cancer is also
the fifth deadliest cancer for adult women, with an
80% recurrence rate within the first 2 years after
ending primary treatment.3 While advanced treatment
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this is far from routinely implemented. The uptake
of survivorship care plans remains challenging given
lack of consensus about data elements to be included
in follow-up plans, timing, heterogeneous disease
trajectories across and within cancer types, increased
(and often unpaid) time required to create and
distribute survivorship care plans, and lack of evidence
concerning the benefits of these plans.8 Although
intended to improve patient-provider communication
and facilitate shared decision-making at the end of
treatment, the difficulty in implementing survivorship
care plans has prevented patients from seeing the
benefits of these plans.

“tweet,” which is limited to ~140 characters. A growing
number of cancer patients are finding supportive
communities on Twitter, including gynecologic cancer
patients. The #gyncsm (gynecologic cancer social
media) hashtag identifies tweets of interest to those
whose lives have been impacted by a gynecologic
cancer. The hashtag is also used for monthly Twitter
chats, which cover educational and patient-focused
topics. Health care providers, including one author of
this paper (D.S.D.), regularly participate as health care
moderators in these chats to provide education and
resources to patient groups.

Patients’ supportive needs at the end of treatment
remain largely unknown by clinicians and researchers
alike.9-11 However, identifying these needs is critical
to ensuring survivorship care plans fully address
the informational, physical, emotional, and support
requirements of the ovarian cancer patient population.
By understanding patient needs, clinicians can
proactively provide resources that increase both
quality of life and health during their survivorship
experience and assist individuals in earlier recognition
of recurrence or late-term treatment effects.

We conducted a digital content analysis of a moderated
online discussion forum using the social media platform
Twitter, accessing a diverse group of stakeholders
knowledgeable about the needs of patients with
ovarian cancer. This online discussion was conducted
as a regularly scheduled #gyncsm Twitter chat titled
“Re-envisioning Ovarian Cancer Survivorship.” The
chat was advertised to this active, public social media
community (#gyncsm) so we could obtain a broader
perspective of the needs of individuals with ovarian
cancer in the survivorship period of their disease. We
publicized the discussion, through Twitter, to followers
of the Ovarian Cancer Research Fund Alliance, Society
for Gynecological Oncology, Foundation for Women’s
Cancer, and the National Ovarian Cancer Coalition.

Twitter (Twitter, Inc., San Francisco, CA) is a
microblogging social media platform in which people
with an account can initiate, discuss, and exchange
ideas. Due to its popularity as a mechanism to share and
exchange ideas, Twitter attracts lay and professional
individuals to engage with each other to share pertinent
topics.12 Participants share their ideas in the form of a

METHODS

The Twitter chat posed 5 questions, developed by the
moderators and approved by the authors, to participants
(Table 1). To engage participants in deep yet targeted

Table 1. Twitter Chat Questions
Order

Question

T1

A. What does survivorship mean to you? What is it to be an ovarian cancer survivor?
B. Do you use the term survivor? If not, what term do you prefer?

T2

What needs and concerns did you have when you were first diagnosed and treated? How were they addressed?
What was lacking?

T3

How was the topic of recurrence addressed with you? Did you find it helpful or not helpful at the time –– and now
looking back?

T4

A. What issues –– physical, emotional or other –– currently give you the most difficulty?
B. W
 hat are your needs and concerns now (after recurrence, or, as you live past diagnosis and initial treatment
of ovarian cancer)?

T5

What actions have you taken in living past your ovarian cancer diagnosis and treatment? Were you given a
survivorship care plan?
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discussion, we developed open-ended questions
that elicited participant experiences of survivorship
including their needs, supportive care received, and
unmet needs. Participants were invited to respond to
each question and asked to tag their specific tweets to the
topic or question to which they were responding (T1A,
T1B, T2, etc). Survivors, if comfortable doing so, were
invited to identify the year they were diagnosed and
their primary cancer type and stage. The Twitter chat
moderator reinforced that the #gyncsm hashtag and
the Twitter chat were not forums for medical advice.
Authors (T.H.T, D.S.D) also moderated the Twitter
chat to ensure the accuracy and appropriateness of all
messages. At the beginning and end of the Twitter chat,
participants were provided with online resources and
supportive services for ovarian cancer survivors.
A mixture of qualitative and quantitative data analysis
tools was used to assess participant responses. First,
we performed a quantitative analysis of the words used
by patients using Symplur Signals (Los Angeles, CA),
a company specializing in health care social media
analytics. The company’s algorithm for assessing
word sentiment is based on a scaling system of
neutral, positive, and negative words used in health
care conversations on Twitter (more details can be
found at https://help.symplur.com/reports/content/
sentiment). Unlike traditional qualitative analyses,
evaluating patients’ sentiments allowed us to assess the
overarching disposition of tone using rigorous methods
included in this software.
Second, we qualitatively analyzed participant
responses to the 5 Twitter chat questions to extract
common ideas across participants. Descriptive content
analysis methodologies were applied with the goal
of organizing participant responses and reducing the
data to common themes.13 Participant descriptions of
their survivorship experiences were summarized and
interpreted to create shared narratives and identify
unmet needs and barriers to care.
Because this study was mostly interested in the selfreported needs and preferences of survivors, we
prioritized tweets from the 15 apparent patients above
tweets from providers, caregivers, and advocates in
order to focus on those with first-hand experience
of ovarian cancer. The first author, who is trained in
qualitative data analysis and rigor, reviewed all tweets
Original Research

and provided basic descriptions for initial review by
K.N. and for validation by D.S.D. Once confirmed,
the codes were applied to all participant responses and
summarized with general themes that were confirmed by
all study team members. We also used basic descriptive
statistics to describe the 1) number of tweets, 2) number
of retweets (original tweets that are then shared by
others), 3) most frequently used words, and 4) sentiment
of frequently used words (either positive or negative).
This study was conducted using a social media platform
in which participant responses are publicly available.
Therefore, the institutional review board did not require
human subjects approval because the analysis only
included tweets shared with the #gyncsm hashtag that
are not intended to be private, no individual interaction
occurred between participants and the research team,
and Twitter’s privacy policy explicitly states that all
information shared within its website is intended
to be broadly shared and that users had minimal
expectations for privacy while using the website.14
The chat leaders noted at the beginning of the event
that information shared with the #gyncsm would be
publicly available, offered participants the opportunity
to “listen” only if they were uncomfortable sharing,
and referred participants to a disclaimer explaining
privacy concerns and medical information (http://
gyncsm.blogspot.com/p/tweet-disclaimer.html).

RESULTS

The chat occurred on April 13, 2016, from 9 to 10 p.m.
Eastern Daylight Time, the usual Twitter chat time for
the #gyncsm community. We allotted 10 minutes to
discuss each of the 5 questions. The #gyncsm leaders
initiated each question, and participants responded in
real time to each question, though some participants
answered questions at a later time.
Quantitative Analysis
The chat included 377 unique and original tweets and
had postings from 43 stakeholder participants during
and immediately after the Twitter chat (total: 1 hour,
15 minutes), with 60 additional participants adding to
the conversation in the day following the Twitter chat.
Among participants, 32% identified as survivors and
10.7% were physicians. Other participants included
family caregivers, patient advocates, and other
clinicians such as social workers. Each participant
posted an average of 8.64 tweets.
www.aurora.org/jpcrr
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The word bubbles in Figure 1 illustrate the most
commonly stated words during the Twitter chat. The
largest bubbles reflect descriptive words, such as
“cancer,” “ovarian,” and “survivorship,” that reflected
the topic of conversation. Notably, words such as
“support,” “lacking,” “living,” and “advocate” align
with participants’ statements indicating dissatisfaction
with the currently available health care services for
ovarian cancer survivors. They indicated the need for
additional support to live full, meaningful and healthy
lives.
Figure 2 compares the word frequency of positive
and negative sentiment words used during the Twitter
chat. Overall, participants used words with a positive
sentiment more frequently than words with a negative
sentiment, though most of the positive words were
general in nature (eg, “good,” “welcome,” and “join”).
Remarkable positive sentiment words like “thanks/
thank,” “support,” and “care” reflected participants’

discussion of survivors’ needs and their thanks for
support they felt from the Twitter chat and caregivers.
By comparison, words with a negative sentiment were
much more striking. While prompted to discuss their
unmet needs, the tone of participants’ word choices
reflected the neglect they sensed from their health care
providers and the fear they felt while ending treatment.
“Struggle,” “loss,” “panic,” and “scary” paint a picture
in which survivors feel abandoned in the midst of an
intense fight, potentially reflecting the fear and worry
survivors stated having when treatment ends and the
sense of control and connection with their health care
providers is broken.
Qualitative Analysis
Common themes expressed by participants in the
Twitter chat described feeling lost after initial
treatment, with continued and new symptoms and side
effects from treatment. Women expressed that while

Figure 1. Word bubble
illustrating Twitter chat
word frequency.
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Figure 2. Word frequency by positive and negative sentiment.

they had practical concerns during treatment, their
concerns transitioned to becoming more emotional
ones in the remission phase. Moreover, few survivors
reported receiving a survivorship care plan from their
oncology team, and many described a lack of guidance
concerning their fears of recurrence, quality-of-life
concerns, and symptoms such as neuropathy, memory
problems, anxiety, and sleep.
Table 2 lists quotations from the chat representative
of common concerns experienced by women with
ovarian cancer going off active treatment. Participants
defined their period of survivorship as a time in which
they focused on attempting to live well and regain the
quality of life they lost during treatment. Nonetheless,
they reported concerns related to loss of control,
uncertainty, and the possibility their cancer could recur.
Most women preferred not to be called a “survivor,”
some suggesting the term “thriver” or someone “in
remission” rather than someone who is completely
finished with their treatment. Most agreed that the way
in which a survivor defines herself should be personally
defined rather than imposed on them from others.
While undergoing treatment, survivors recalled their
needs as centering around practical concerns, acute

Original Research

symptoms, accessing support and patient stories, and
receiving referrals to additional support services.
Participant A: “Most concerned about chemo &
vomiting.”
 articipant B: “Women seem to seek first to know
P
they are not alone and also practical concerns that
come with treatment.”
 articipant C: “I feel what is missing is more stories
P
of women living with OC. When I was first diagnosed
I was sure I would not survive.”

Table 2. Selected Quotations From Twitter Chat
Quotation

Retweets

Survivorship is more about living than
surviving.

8

Recurrence is such a hard topic, but I've
read too many stories of women who felt
slammed because it wasn't discussed at all.

7

We still have work to do to improve
gynecology patient education on side
effects, emotional needs.

6

www.aurora.org/jpcrr
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In terms of their current concerns, survivors reported
having continued symptom management needs,
especially for anxiety, sleep concerns, memory
problems, and peripheral neuropathy. They also
reported significant worries about their cancer coming
back and regarding end-of-life issues: “Too much
avoidance [among health care providers] of endof-life discussions when needed, death still taboo
topic” (Participant D). Symptoms gave survivors the
most difficulty, along with managing the possibility
of a recurrence. A couple of participants mentioned
that guidelines for detecting a recurrence were often
unclear and could lead to aggressive testing.
Participant E: “Need clear guidelines [for] longterm remission after multiple recurrences, followup-scans, CA-125. [Gynecological oncologist and
medical oncologist] opinions differ.”
 articipant C: “Leg pain from [carboplatin/taxol] still
P
present. Issues with my sleep. 6 months post chemo.
Told leg pain was a chemo gift and would stay.”
Survivors reported managing their illness by
maintaining a sense of self and engaging in healthy
behaviors such as being physically active, eating a
healthy diet, and reducing stress. One survivor noted
that she has become a research advocate and provides
peer support to other ovarian cancer patients.
Participant B: “Serve ovarian cancer community as
research advocate and provide peer support.”
When asked about how their health care providers
addressed the topic of whether or not they had received
a care plan when ending treatment, survivors reported
a low amount of support. Only one survivor said she
had received a survivorship care plan when she ended
her treatment. While many survivors noted that they
had become involved in advocacy organizations, peer
support groups, or both, they simultaneously noted
needing personal space to “take frequent breaks from
being all teal [the ribbon color for ovarian cancer]
to being just me” (Participant E). One survivor
reported feeling like a “rudderless ship” (Participant
A) after treatment ended because of the high number
of sensitive, less-clearly addressed issues she faced
without anyone to steer or guide her along the way. On
the other hand, one woman (Participant E) described
the posttreatment phase as being a time when she was
recapturing and redefining her identity: “Free to be me
again despite history of cancer or fears!”
154 JPCRR • Volume 5, Issue 2 • Spring 2018

DISCUSSION

It is unsurprising yet confirmatory that survivors
and stakeholders alike agreed that ovarian cancer
survivors receive little support as they transition into the
survivorship period of their cancer experience. Although
women reported ongoing physical and emotional needs
that were largely unaddressed by their providers, they
continued to find ways to manage their health and
maintain a sense of self. Given that so many women
will recur and will continue to experience severe and
distressing symptoms after treatment is over, this gap in
care should serve as a call to action. In this Twitter chat,
survivors noted that they wanted their trusted health
care professionals to proactively equip them with the
supportive care resources they will need but may not
have the means or regular clinic appointments with their
health care team to subsequently request.
Survivorship care plans primarily emphasize the
supportive care of patients who complete curative intent
treatment and for whom there is a high probability
of long-term survival.7 These plans aim to help this
population receive evidence-based, coordinated care.
Key to patients’ long-term health, survivorship care
plans help bridge oncology and primary care. One study
demonstrated that when oncologists share survivorship
care plans with a patient’s primary care provider, the
primary care provider is 9 times more likely to discuss
survivorship issues with the patient; yet, the unclear
delineation of patient care responsibilities and lack of
training in oncology and survivorship care remain barriers
to primary care providers delivering follow-up care to
survivors.15 Moreover, most patients with ovarian cancer
prefer to receive continued care from their oncologist.16
The Society of Gynecologic Oncology has published
its version of a survivorship care plan, called the
Survivorship Toolkit, which contains resources aimed
for patients completing therapy.17 However, as with
other survivorship care plans, it assumes all patients
who require a survivorship care plan are being treated
with curative intent and does not address the needs
of patients who eventually relapse.18 Furthermore, it
does not address the totality of patient needs beyond
medical care, such as the emotional issues and coping
discussed by patients in this study and the evaluation
and treatment for pelvic/lower-extremity lymphedema,
genitourinary symptoms of menopause, and sexual
health. As a result, there is very little guidance as to
Original Research

what survivorship care should look like for women
who face a high risk of recurrence, those who recur,
and those with advanced or metastatic disease who
may not “complete” curative intent therapy.
Our finding that few patients received survivorship
care plans despite facing ongoing needs reflects the
lack of effective survivorship care models that fulfill
the Institute of Medicine’s 2006 recommendation.”7
Nonetheless, the Commission on Cancer is mandating
the implementation of survivorship care plans within
its accredited hospitals,19 and research demonstrating
how to do so within ovarian cancer is desperately
needed. In one of the few trials that looked at women
with a gynecologic cancer, Nicolaije et al20 reported
results of a randomized controlled trial that compared
an automatically generated survivorship care plan to
usual care among women with endometrial cancer.
While 74% of patients randomly assigned to receive a
survivorship care plan actually received one, there was
no difference in satisfaction with either information
or care compared to those in the usual care arm. Of
concern, survivorship care plans were associated with
elevated levels of patient concerns, emotional impact,
and symptoms. Similarly, a randomized clinical trial
reported by de Rooij et al found that, compared to
women with ovarian cancer who did not receive a
survivorship care plan, those who did receive a plan
reported no differences in satisfaction and had lower
beliefs that treatment would help cure their disease.21
A current trial (NCT03035773) sponsored by Sidney
Kimmel Comprehensive Cancer Center in collaboration
with Patient-Centered Outcomes Research Institute
and guided by a stakeholder advisory board is
evaluating three models of survivorship care planning
to determine which model is feasible, effective, and
patient-centered. While this study will not recruit
women with gynecologic cancer, these prospective
studies evaluating patient-centered survivorship care
have direct implications for the care of patients with
ovarian cancer and similar studies can be implemented
within the ovarian cancer population.
Future research should focus on how health care
providers and cancer advocacy organizations can
continue to support women with ovarian cancer after they
end first-line treatment. In fact, the National Academies
of Sciences, Engineering, and Medicine emphasized the
Original Research

need for prospective studies that are specific to ovarian
cancer; appreciate differences in patient age, race, and
ethnicity; and reveal risk factors for specific issues in
survivorship.22 Understanding their needs and providing
continuous support can ensure that survivors do not feel
like they are being abandoned after treatment, living in
uncertainty and fear. Likewise, research should consider
the needs of patients with ovarian cancer who recur and
those who require continuous treatment, since these
survivors need assistance living with the disease rather
than living after the disease. We must find ways to
provide care plans and support systems that proactively
address the emotional and physical concerns so prevalent
within this patient population.
As researchers continue to identify and test the efficient,
clinically beneficial ways to support ovarian cancer
survivors, clinicians must continue to review and
enact evidence-based standards for survivorship care.
For example, the Society of Gynecologic Oncology
published recommendations in 2011, with an update
in 2017, for the posttreatment care for survivors of
gynecologic cancer, including ovarian cancer.23,24
Clinicians can use survivorship care guidelines set by
the American Society of Clinical Oncology and other
national cancer organizations to address the multitude
of ongoing physical and psychosocial symptoms faced
by many cancer survivors.25
Limitations
Compared to traditional focus groups, Twitter chats
offer distinct benefits and challenges. We were able
to access a wide-ranging group of participants from
across the United States who self-identified as being
interested in this topic. However, our sample did not
include ovarian cancer survivors who do not have
Twitter accounts or were not comfortable using social
media to share information and opinions regarding
their cancer care. Also, given the heterogeneity of
our sample and the short window in which questions
were asked, participants may or may not have felt
comfortable building off of each other’s comments,
as is typically done during a focus group. Another
limitation is the bias in attracting participants who
already engage in social media and internet support.
While the richness of other qualitative methodologies
may be lacking, the ability to quickly capture the
central themes of survivors’ experiences makes Twitter
chats an attractive qualitative method.
www.aurora.org/jpcrr
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CONCLUSIONS

Results of this Twitter chat suggest that ovarian cancer
survivors receive minimal information to guide their
health and well-being during the survivorship period.
Health care providers must prepare these patients as
they end treatment for the physical, psychological,
and social needs we know they will likely face.
Survivorship care plans must be tailored to meet the
unique concerns and cancer experience of this patient
population. The health care and advocacy communities
must reach out to these patients as they transition from
active treatment to surveillance. This vulnerable time
in patients’ lives is our opportunity to demonstrate our
understanding of their needs and concerns.

Patient-Friendly Recap
• Due to high rates of recurrence, patients with
ovarian cancer require long-term supportive
health care.
• The authors recruited ovarian cancer survivors
to participate in a moderated Twitter chat to
discuss their experiences after treatment.
• Contrary to the Commission on Cancer's
recommendations, few survivors receive
detailed care plans when their treatment ends.
• Survivors expressed a desire for health
providers to proactively offer resources that
could help address future emotional and
physical needs.
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